Statements (71)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:accessories |
Works with various suppliers
|
| gptkbp:acquisition |
Kobe Steel's medical division
|
| gptkbp:advances |
Invests in new technologies
|
| gptkbp:awards |
Various industry awards
|
| gptkbp:business_model |
B2 B and B2 C
|
| gptkbp:ceo |
Hisashi Ietsugu
|
| gptkbp:clinical_trial |
Involvement in clinical research
|
| gptkbp:collaboration |
Various academic institutions
|
| gptkbp:collaborations |
Collaborates with leading universities
|
| gptkbp:community_engagement |
Engages in local community activities
|
| gptkbp:cultural_diversity |
Promotes diversity in the workplace
|
| gptkbp:customer_base |
Hospitals and laboratories
|
| gptkbp:customer_feedback |
Actively seeks customer input
|
| gptkbp:customer_satisfaction |
High customer satisfaction ratings
|
| gptkbp:customer_support |
24/7 support services
|
| gptkbp:employees |
approximately 8,000
|
| gptkbp:expansion |
Continued global expansion
|
| gptkbp:financial_performance |
Strong financial growth
|
| gptkbp:financial_stability |
Stable financial position
|
| gptkbp:focus |
In vitro diagnostics
|
| gptkbp:founded |
gptkb:1968
|
| gptkbp:founder |
gptkb:Toshio_Saito
|
| gptkbp:global_presence |
Over 30 countries
|
| gptkbp:headcount |
8,000+
|
| gptkbp:headquarters |
gptkb:Kobe,_Japan
gptkb:Kobe,_Hyogo_Prefecture |
| https://www.w3.org/2000/01/rdf-schema#label |
Sysmex Corporation
|
| gptkbp:industry |
Medical devices
|
| gptkbp:innovation |
Leader in hematology technology
|
| gptkbp:invention |
Numerous patents in diagnostics
|
| gptkbp:investment |
Invests in R& D
|
| gptkbp:leadership |
Leader in hematology analyzers
|
| gptkbp:market |
Global
Conducts extensive market research |
| gptkbp:market_launch |
Regularly introduces new products
|
| gptkbp:market_share |
Significant in hematology
|
| gptkbp:mission |
To provide advanced diagnostic solutions
|
| gptkbp:part_of |
Sysmex Group
|
| gptkbp:partnership |
gptkb:Roche_Diagnostics
|
| gptkbp:partnerships |
Collaborations with healthcare providers
|
| gptkbp:product |
Continuous innovation in diagnostics
|
| gptkbp:product_line |
Wide range of diagnostic products
|
| gptkbp:product_quality |
Strict quality assurance processes
|
| gptkbp:products |
Clinical chemistry analyzers
Hematology analyzers Coagulation analyzers Urinalysis systems |
| gptkbp:regulatory_compliance |
Meets international standards
|
| gptkbp:research_and_development |
gptkb:Yes
|
| gptkbp:revenue |
¥ 100 billion (2020)
|
| gptkbp:service |
Technical support and training
|
| gptkbp:side_effect |
Significant impact on global healthcare
|
| gptkbp:social_responsibility |
Health education programs
Active in community health initiatives |
| gptkbp:stock_exchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stock_symbol |
6869
|
| gptkbp:strategy |
Focus on emerging markets
|
| gptkbp:subsidiaries |
Sysmex America, Inc.
Sysmex Asia Pacific Sysmex Europe Gmb H |
| gptkbp:supply_chain |
Global supply chain management
|
| gptkbp:sustainability |
Commitment to environmental practices
|
| gptkbp:technology |
Automated analyzers
|
| gptkbp:trademark |
Sysmex
|
| gptkbp:training |
Ongoing professional development
|
| gptkbp:training_programs |
Comprehensive training for users
|
| gptkbp:vision |
To contribute to healthcare
|
| gptkbp:website |
www.sysmex.com
|
| gptkbp:bfsParent |
gptkb:Coulter_Corporation
|
| gptkbp:bfsLayer |
6
|